These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25492294)
41. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage. Au WW; Henderson BR Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442 [TBL] [Abstract][Full Text] [Related]
42. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840 [TBL] [Abstract][Full Text] [Related]
43. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569 [TBL] [Abstract][Full Text] [Related]
44. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G; Besnard E; Fisher D; Piette J; Dulić V Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626 [TBL] [Abstract][Full Text] [Related]
45. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Jacquemont C; Taniguchi T Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210 [TBL] [Abstract][Full Text] [Related]
46. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. Khanna KK; Beamish H; Yan J; Hobson K; Williams R; Dunn I; Lavin MF Oncogene; 1995 Aug; 11(4):609-18. PubMed ID: 7651723 [TBL] [Abstract][Full Text] [Related]
47. BRCA1 and BRCA2 heterozygosity in embryonic stem cells reduces radiation-induced Rad51 focus formation but is not associated with radiosensitivity. Sioftanos G; Ismail A; Föhse L; Shanley S; Worku M; Short SC Int J Radiat Biol; 2010 Dec; 86(12):1095-105. PubMed ID: 20979543 [TBL] [Abstract][Full Text] [Related]
48. Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo. Tassone P; Di Martino MT; Ventura M; Pietragalla A; Cucinotto I; Calimeri T; Bulotta A; Neri P; Caraglia M; Tagliaferri P Cancer Biol Ther; 2009 Apr; 8(7):648-53. PubMed ID: 19333003 [TBL] [Abstract][Full Text] [Related]
49. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cistulli CA; Kaufmann WK Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844 [TBL] [Abstract][Full Text] [Related]
50. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Tassone P; Tagliaferri P; Perricelli A; Blotta S; Quaresima B; Martelli ML; Goel A; Barbieri V; Costanzo F; Boland CR; Venuta S Br J Cancer; 2003 Apr; 88(8):1285-91. PubMed ID: 12698198 [TBL] [Abstract][Full Text] [Related]
51. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function. Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826 [TBL] [Abstract][Full Text] [Related]
52. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin. Koehn H; Magan N; Isaacs RJ; Stowell KM Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394 [TBL] [Abstract][Full Text] [Related]
53. Accumulation of p21 proteins at DNA damage sites independent of p53 and core NHEJ factors following irradiation. Koike M; Yutoku Y; Koike A Biochem Biophys Res Commun; 2011 Aug; 412(1):39-43. PubMed ID: 21787748 [TBL] [Abstract][Full Text] [Related]
54. BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. Tulchin N; Chambon M; Juan G; Dikman S; Strauchen J; Ornstein L; Billack B; Woods NT; Monteiro AN Am J Pathol; 2010 Mar; 176(3):1203-14. PubMed ID: 20075200 [TBL] [Abstract][Full Text] [Related]
55. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage. Udden SM; Morita-Fujimura Y; Satake M; Ikawa S Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958 [TBL] [Abstract][Full Text] [Related]
56. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Girinsky T; Koumenis C; Graeber TG; Peehl DM; Giaccia AJ Cancer Res; 1995 Sep; 55(17):3726-31. PubMed ID: 7543816 [TBL] [Abstract][Full Text] [Related]
57. Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKCζ-p53-p21 signaling pathway. Jung SH; Lee HC; Hwang HJ; Park HA; Moon YA; Kim BC; Lee HM; Kim KP; Kim YN; Lee BL; Lee JC; Ko YG; Park HJ; Lee JS Cell Death Dis; 2017 May; 8(5):e2793. PubMed ID: 28518146 [TBL] [Abstract][Full Text] [Related]
58. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage. Yamane K; Schupp JE; Kinsella TJ Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687 [TBL] [Abstract][Full Text] [Related]
59. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850 [TBL] [Abstract][Full Text] [Related]
60. TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro. Rasti M; Azimi T Avicenna J Med Biotechnol; 2015; 7(2):76-9. PubMed ID: 26140185 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]